News Announcement

Zydus Lifesciences: Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus announces final approval from the USFDA for Ascorbic Acid Injection with 180-Days CGT exclusivity.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.